GSK3A and early-onset autosomal dominant Alzheimer disease: Two isoforms, GSK3α and GSK3β, have been identified and both are ubiquitously expressed in the brain and GSK3β is increased in the post-mortem brain of Alzheimer’s disease patients [26].